Sareum Holdings (LSE:SAR) 3-Year EBITDA Growth Rate : -48.50% (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Sareum Holdings 3-Year EBITDA Growth Rate?

Sareum Holdings's EBITDA per Share for the six months ended in Dec. 2023 was £-0.04.

During the past 3 years, the average EBITDA Per Share Growth Rate was -48.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -13.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Sareum Holdings was 51.50% per year. The lowest was -48.50% per year. And the median was 3.35% per year.

Competitive Comparison of Sareum Holdings's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Sareum Holdings's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sareum Holdings's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sareum Holdings's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Sareum Holdings's 3-Year EBITDA Growth Rate falls into.

Sareum Holdings 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Sareum Holdings (LSE:SAR) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Sareum Holdings 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Sareum Holdings's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sareum Holdings (LSE:SAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sareum Holdings PLC (LSE:SAR) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

RYH0:Germany

Address

Langford Arch, London Road, Unit 2a, Pampisford, Cambridge, Cambridgeshire, GBR, CB22 3FX

Website

http://www.sareum.com

Sareum Holdings PLC is engaged in drug discovery and development. The company is focused on cancer and autoimmune diseases and licensing them to pharmaceutical and biotechnology companies. The company's drug pipeline includes SDC-1801 for autoimmune diseases, SDC-1802 for cancers, SRA737 targeting solid tumors among others.